Description

Felodipine is a dihydropyridine calcium channel blocker commonly used in research to study vascular resistance, arterial compliance, and pharmacodynamics of antihypertensive agents. It selectively inhibits L-type calcium channels, reducing peripheral vascular resistance by promoting vasodilation.

This product contains 5mg of felodipine per extended-release tablet, supplied as 9 tablets per box. Manufactured by Laiyang Jiangbo Pharmaceutical Co., Ltd., approved by the China NMPA (H20103190) and intended strictly for laboratory research use.

?? For laboratory research only. Not for human or veterinary use. Not for clinical or diagnostic applications.

Felodipine Extended-Release Product Specifications

Felodipine Extended-Release Mechanism & Research Applications

Felodipine inhibits voltage-gated L-type calcium channels in vascular smooth muscle, leading to vasodilation and reduced peripheral resistance. It does not significantly affect cardiac conduction or contractility, making it ideal for isolating vascular effects in research.

Researchers use felodipine to study:

• Vascular tone regulation

• Hypertension models

• Calcium signaling pathways

• Pharmacokinetics of extended-release delivery

• Dihydropyridine class comparison

Felodipine Extended-Release Potential Side Effects (In Research Settings)

In experimental models, felodipine may cause:

• Dose-dependent hypotensive responses

• Reflex tachycardia in cardiovascular studies

• Mild gastrointestinal disturbance in long-term exposure

Safety & Handling

• Use Restriction: Laboratory use only. Not approved for human or veterinary use.

• Protective Gear: Lab coat, gloves, and eye protection recommended.

• Disposal: Follow institutional safety and chemical waste guidelines.

Research Use Disclaimer

Felodipine Extended-Release is strictly for laboratory research. Not intended for therapeutic, diagnostic, or veterinary purposes. Improper handling may lead to regulatory and safety risks.